Related Experiment Videos
Therapeutic concentrations of griseofulvin do not affect yeast cell phagocytosis by monocytes
Abstract:
The effect of griseofulvin on monocyte phagocytosis was assessed by studying the uptake of fluorescent yeast cells by glass-adherent monocytes (a fluorescence-quenching technique). In contrast to other microtubule antagonists, griseofulvin did not inhibit monocyte phagocytosis. It is suggested that the lack of griseofulvin interference with essential leukocyte functions is a possible explanation for the fact that the microtubule antagonist griseofulvin serves as a comparatively safe and harmless drug.
Insights
Griseofulvin, an antifungal drug, does not hinder monocyte phagocytosis, unlike other microtubule inhibitors. This lack of interference with immune cell function may explain its safety profile.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Griseofulvin is a widely used antifungal medication.
- Microtubule antagonists can interfere with essential cellular functions.
- The impact of griseofulvin on immune cell function, specifically phagocytosis, requires clarification.
Purpose of the Study:
- To investigate the effect of griseofulvin on monocyte phagocytosis.
- To compare griseofulvin's effect with other microtubule antagonists.
Main Methods:
- Monocyte phagocytosis was assessed using a fluorescence-quenching technique.
- Uptake of fluorescent yeast cells by glass-adherent monocytes was measured.
Main Results:
- Griseofulvin did not inhibit monocyte phagocytosis.
- This finding contrasts with the effects of other known microtubule antagonists.
Conclusions:
- Griseofulvin does not interfere with the phagocytic function of monocytes.
- This lack of interference with leukocyte functions may contribute to griseofulvin's established safety and tolerability as a drug.